A study on FGF23 among chronic renal failure patients in Perambluar District

Journal Title: International Archives of Integrated Medicine - Year 2019, Vol 6, Issue 1

Abstract

Background: Fibroblast growth factor 23 (FGF23) is a phosphate-regulating hormone primarily secreted by osteocytes. Levels of FGF23 increase as kidney function declines as a physiologic response to maintain normal serum phosphate levels and neutral phosphate balance. Although FGF23 helps to prevent hyperphosphatemia, elevated circulating levels are independently associated with vascular dysfunction, left ventricular hypertrophy, increased risk for ESRD, and death in patients with CKD. Aim of the study: To evaluate the FGF23 and eGFR levels in chronic kidney disease patients to compare them with healthy controls. Materials and methods: Totally 100 patients were included in the study. The study was conducted from June 2018 – November 2018 over a period of 6 months at Nephrology department of DSMCH, Perambalur. Group – I (50) who were in CKD stage - IV. Group - II (50) healthy controls were included in the study. Fibroblast growth factor 23 (FGF23) was estimated by standard techniques and results are analyzed accordingly. Results: The mean value of FGF23 in Group – I was 730.7 ± 492.72 pg/ml was higher than that of the Group – II whose mean value was 39.49 ± 12.47 pg/ml and this difference was statistically significant( p<0.05). Group – I had very low mean eGFR levels than Group - II and this difference was statistically significant. Conclusion: Higher FGF23 levels are independently associated with higher levels of inflammatory markers in patients with CKD and with significantly greater odds of severe inflammation. Future studies should evaluate whether inflammation modifies the association between FGF23 and adverse outcomes in CKD.

Authors and Affiliations

G. Kavitha, Nageshwari A

Keywords

Related Articles

Comparative study of hemoglobin and packed volume levels in term and preterm babies delivered in RMMCH

Background: Most existing accounts of hemoglobin values in healthy premature infants covering the early weeks of life were written before many of the errors of such determinations were recognized. Because of these limita...

Factors influencing sleep quality and its impact on glycemic control in patients with type II diabetes mellitus - A hospital based cross sectional study

Background: The absolute number of diabetic population worldwide has raised from 108 million in 1980 to 422 million in 2014. Many western studies documented that diabetes affects the patient’s sleep quality negatively an...

Fast food addiction – The junk enslavement

Research question: What extent do we crave for fast foods? Background: Fast foods are consumed in larger quantities intended with persistent desire or futile efforts to minimise or to cease the intake of these items; hen...

A case series on gastro intestinal stromal tumors at various sites

Gastrointestinal stromal tumors (GIST) represent only 0.1 to 3% of all gastrointestinal malignances. They are neoplasms with varying malignant potential ranging from virtually indolent tumors to rapidly progressing tumor...

Role of probiotic for impetigo in children

Back ground: Impetigo is the most common bacterial infection in children. This acute, highly contagious infection of the superficial layers of the epidermis is primarily caused by Staphylococcus aureus or Streptococcus P...

Download PDF file
  • EP ID EP673364
  • DOI -
  • Views 153
  • Downloads 0

How To Cite

G. Kavitha, Nageshwari A (2019). A study on FGF23 among chronic renal failure patients in Perambluar District. International Archives of Integrated Medicine, 6(1), 35-40. https://europub.co.uk/articles/-A-673364